Arrowhead Pharmaceuticals, Inc. (ARWR)
NASDAQ: ARWR · Real-Time Price · USD
13.97
+0.94 (7.21%)
At close: May 12, 2025, 4:00 PM
15.12
+1.15 (8.23%)
After-hours: May 12, 2025, 7:59 PM EDT

Arrowhead Pharmaceuticals Income Statement

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20 2015 - 2019
Revenue
545.213.55240.74243.23138.2987.99
Upgrade
Revenue Growth (YoY)
1436.97%-98.52%-1.03%75.89%57.16%-47.87%
Upgrade
Gross Profit
545.213.55240.74243.23138.2987.99
Upgrade
Selling, General & Admin
125.28124.54108.82132.4485.4454
Upgrade
Research & Development
538.48480.09336.92289.3201.88127.15
Upgrade
Operating Expenses
663.76604.63445.74421.74287.32181.15
Upgrade
Operating Income
-118.55-601.08-205-178.51-149.04-93.16
Upgrade
Interest Expense
-41.39-32.35-18.33---
Upgrade
Interest & Investment Income
21.2722.7215.35.036.129.19
Upgrade
Other Non Operating Income (Expenses)
-13.6-1.751.540.772.07-0.6
Upgrade
EBT Excluding Unusual Items
-152.27-612.46-206.49-172.71-140.85-84.57
Upgrade
Gain (Loss) on Sale of Investments
-----0.02
Upgrade
Pretax Income
-152.27-612.46-206.49-172.71-140.85-84.55
Upgrade
Income Tax Expense
2.4-2.772.783.7900
Upgrade
Earnings From Continuing Operations
-154.68-609.69-209.28-176.49-140.85-84.55
Upgrade
Minority Interest in Earnings
10.7110.240.43--
Upgrade
Net Income
-143.97-599.49-205.28-176.06-140.85-84.55
Upgrade
Net Income to Common
-143.97-599.49-205.28-176.06-140.85-84.55
Upgrade
Shares Outstanding (Basic)
127120107105104101
Upgrade
Shares Outstanding (Diluted)
127120107105104101
Upgrade
Shares Change (YoY)
14.17%12.21%1.26%1.62%3.00%2.14%
Upgrade
EPS (Basic)
-1.13-5.00-1.92-1.67-1.36-0.84
Upgrade
EPS (Diluted)
-1.13-5.00-1.92-1.67-1.36-0.84
Upgrade
Free Cash Flow
--604.32-330.63-188.91147.75-107.75
Upgrade
Free Cash Flow Per Share
--5.04-3.10-1.791.42-1.07
Upgrade
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Upgrade
Operating Margin
-21.75%-16927.06%-85.16%-73.39%-107.77%-105.87%
Upgrade
Profit Margin
-26.41%-16882.37%-85.27%-72.39%-101.85%-96.09%
Upgrade
Free Cash Flow Margin
--17018.31%-137.34%-77.67%106.84%-122.46%
Upgrade
EBITDA
-98.28-582.49-192.51-168.09-140.77-87.22
Upgrade
EBITDA Margin
-18.02%--79.97%-69.11%-101.79%-99.12%
Upgrade
D&A For EBITDA
20.2818.612.4910.428.275.94
Upgrade
EBIT
-118.55-601.08-205-178.51-149.04-93.16
Upgrade
EBIT Margin
-21.75%--85.16%-73.39%-107.77%-105.87%
Upgrade
Updated May 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q